BOE A, a leading semiconductor display company that relied on government subsidies for its low performance, has now achieved a virtuous circle of both national industrial development and its own profitability.
Yesterday, the author learned that the seven panel production lines of the company's mass production have basically achieved full production. Among them, 6 TFT-LCD production lines, Beijing 5th generation line, Chengdu 4.5th generation line, Hefei 6th generation line and Beijing 8.5 generation line all maintain high utilization rate. Since 2014, Hefei's 8.5-generation line has exceeded 100K/month of mass production capacity, which has greatly exceeded the design capacity and achieved production in the same year, full production in the same year and profit in the current year. The Chongqing 8.5-generation line was put into operation in March this year, creating the fastest speed in the world from piling construction to product lighting in just 17 months. The company has another 5.5-generation AMOLED production line in Erdos, which has reached the full production status in May this year.
It is reported that as of 2014, China still needs to import about 40 billion US dollars of panels every year, the self-sufficiency rate is only 34%, there is still huge room for improvement. In addition, the new application market represented by vehicle, industrial control, wearables, medical care, etc. has grown significantly, and the future will become the main direction of digesting production capacity.
At present, the company has three production lines in the process of construction, including the 6th generation LTPS/AMOLED production line with a total investment of 22 billion yuan, focusing on high-end mobile phone display and emerging mobile display products. The Hewletian 8.5th generation with a total investment of 30 billion yuan and the Hefei 10.5th generation TFT-LCD production line with a total investment of 40 billion yuan will focus on 60-inch and above large-size ultra-high-resolution high-end smart TVs and digital information displays, and three production lines. They are all saving capacity for new applications.
In recent years, BOE has continued to cooperate with world-renowned customers in new applications. In the field of automotive applications, the company has become a major supplier of public transportation displays in China, and has reached a cooperation intention with top European automotive systems companies; in the field of medical display, the company has successfully supplied 27-inch medical display screens of well-known medical equipment companies, the main application In the field of medical display such as operating table and doctor case analysis; in the field of financial applications, BOE and Ping An Bank have jointly created a smart flagship store for innovative display products such as “anti-peeping†and remote banking.
Since June this year, BOE has issued a report of RMB 3 billion to participate in the medical and health field, with obvious intentions for transformation. The company first acquired 100% equity of Mingde Investment for 250 million yuan, held its core asset Mingde Hospital, and announced a memorandum of cooperation with Dignity, a US medical group, in hospital management operations, medical personnel training, advanced technology introduction and telemedicine cooperation. Cooperation in other areas. Subsequently, the company announced a software license and joint development agreement with IBM, the two sides jointly launched a joint development of health management big data platform based on cognitive computing.
BOE said that entering the smart medical industry is the focus of the company in the second half of the year. The company has clearly identified smart health care services as a strategic transformation direction in the next few years, integrating technologies and resources such as the Internet, big data, cloud computing, information medicine, and sensing. In order to build a second main business.
We, Jiangsu YanFang Medical Technology Co., Ltd, commenced our medical gloves manufacturing in 2020. Currently, we possess a total of 12 high-capacity NBR Glove Dipping Production Lines.
Likewise, we are not only certified with ISO9001, ISO13485 but also fully complied with the essential USFDA, CE Compliances, as well as obtaining relevant accreditation of FDA510K, EN455, and EN374.
Nonetheless, our NBR Examination, Chemotherapy, and Food Grade products are being well established in both US and Europe markets.
We look forward to cooperating and working closely with our valuable customers and stakeholders, who are seeking long-term business relationships in high-quality NBR glove supplies.
Medical Exam Nitrile Gloves,Blue Disposable Nitrile Gloves,Medical Gloves,Examination Nitrile Gloves
Jiangsu Yanfang Medical Technology Co.,Ltd. , https://www.yanfangchina.com